INDEX 



081 



Thyroxin, forms of, keto form, 256 257 

 open ring, 256, 258. 



hydrolysis of, 255. 

 Kendall's method, 256. 



isolation of, by Kendall, 254. 



nature and function of, 232. 



pharmacodynamic actions of, 86. 



propionic acid in, 256. 



qualitative test for, 258. 



- represented by formula, 257. 



susceptibility of, to reduction rather 

 than to oxidation, 258. 



synthesis of, 259. 



terminology of, 6. 



therapeutic action of, 85. 



Tissue, term first employed by de Bor- 

 deu, 46. 



Tongue dimple sign of tetany of F 

 Schultze, 599. 



Tonic spasms, other than of tetany, 

 differentiated from, 676. 



Tonic spasms of tetany. See Tet- 

 any. 



Torticollis, in tetany, 592. 



Toxic theory of exophthalmic goiter, 

 309. 



Transfusion and perfusion experiments, 

 in tetany, 540. 



Trauma, and acromegaly, 808. 



causing dystrophia adiposogenitalis. 

 905. 



as factor in hypothyroidism, 386. 

 Tremor, in exophthalmic goiter, 348. 



in Graves' disease, 349. 

 Trismus, in tetany, 592. 



Trophic changes, in thyroid disease, 



353. 

 Trousseau's phenomenon, 53, 596. 



historical notes on, 581. 



in diagnosis, 674. 



procedure, 596. 



pseudo Trousseau phenomenon, in 

 hysteria, 597. 



Tuberculosis, as a cause of exophthal- 

 mic goiter, 308. 



differentiated from hyperthyroidism, 

 epinephrin hypersensitiveness test 

 (Goetsch) of value in, 482. 



of hypophysis cerebri, 786. 



parathyroid involvement in, 564. 



pulmonary, differentiated from ex- 

 ophthalmic goiter, 360. 



Tuberculous meningitis, differentiated 



from tetany, 676. 

 Tuberculous thyroiditis, 286. 

 Tumors, parathyroid, cysts, 572. 

 metastatic, 573. 



primary neo- 



See 



Tumors, parathyroid, 



plasms, 570. 



table of, 571. 



Tumors, of hypophysis cerebri. 



Hypophysis cerebri, tumors of. 

 pituitary, pituitary (whole) therapy 



m, 122. 



-thyroid gland. See Thyroid gland, 

 tumors. 



TJlcers, bleeding duodenal, epinephrin 

 applications for, 136. 



indolent, tethelin in treatment of, 

 744. 



Urinary constituents, and exophthal- 

 mic goiter, 335. 



Urinary manifestations, of autonomic 

 origin, albuminuria, 335. 



polyuria, 335. 



Urogenital symptoms, of autonomic 

 origin, 334. 



Urticaria, in Graves' disease, 331. 



vasoconstricting action of epineph- 

 rin in, 138. 



Uterine fibroids, mammary gland ther- 

 apy in, 148. 



Uterus, action of epinephrin on, phar- 

 macodynamic, 126. 



effect on, of hypophyseal feeding of 

 posterior lobe, 756. 



Vagotonia, definition and physiology 

 of, 164. 



manifestations of, 165. 



variability of symptomatology as 

 clinically seen, 166. 



Vascular phenomena, of goiter, 317. 



Vascular system, relation to, of supra- 

 renals, 169. 



Vasoconstricting action of epinephrin. 

 See Epinephrin. 



Vasomotor ataxia, history of, 74. 



Vasomotor phenomena, of autonomic 

 origin, 329. 



Vegetative nervous system, changes in, 

 as cause of exophthalmic goiter, 313. 



Vigoroux's sign, 329. 



Visual disturbances, in dystrophia adi- 

 posogenitalis, 866. 



Vitamins, in tetany, 644. 



Vomiting, antispastic action of epi- 

 nephrin in, 139. 



nausea of pregnancy, ovarian ther- 

 apy in, 157. 



of autonomic origin, 332. 

 Von Graefe's sign, 319. 



